Sequence variation in PPP1R13L results in a novel form of cardio-cutaneous syndrome

Tzipora C Falik-Zaccai1,2, Yiftah Barsheshet2, Hanna Mandel3,4

  • 1Institute of Human Genetics, Galilee Medical Center, Nahariya, Israel falikmd.genetics@gmail.com orly.avni@biu.ac.il.

EMBO Molecular Medicine
|January 11, 2017
PubMed

Insights

A novel genetic disorder, dilated cardiomyopathy (DCM) with cardio-cutaneous syndrome, was identified in infants due to a PPP1R13L gene mutation. This mutation impairs iASPP protein function, leading to fatal cardiac inflammation.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a severe heart condition with a largely unknown genetic cause.
  • Infants presented with DCM, skin, teeth, and hair abnormalities, succumbing before age three.

Purpose of the Study:

  • To identify the genetic basis of a novel cardio-cutaneous syndrome presenting with DCM in infants.
  • To investigate the role of the iASPP protein in cardiac inflammation and DCM pathogenesis.

Main Methods:

  • Genetic sequencing identified homozygous variations in PPP1R13L in affected infants.
  • Fibroblast and cardiomyocyte cell models, along with mouse models, were used to study gene function.
  • RNA sequencing and NF-κB pathway analysis were performed to understand molecular mechanisms.

Main Results:

  • A homozygous PPP1R13L mutation causing a premature stop codon was found in affected infants.
  • iASPP deficiency led to increased pro-inflammatory cytokine gene expression and heightened sensitivity to lipopolysaccharide (LPS).
  • NF-κB pathway activation was identified as a key mechanism in the observed cardiac inflammation.

Conclusions:

  • PPP1R13L is identified as the gene responsible for a new autosomal-recessive cardio-cutaneous syndrome.
  • iASPP plays a critical role in regulating cardiac inflammatory responses to common stressors.
  • Failure to regulate these pathways contributes to fatal infantile DCM.

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.7K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.0K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.5K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
731
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593